Tue.Jan 23, 2024

article thumbnail

Mammograms are less effective for women with dense breast tissue. Medical experts disagree on what to do about it

STAT

Millions of American women over age 40 receive regular mammograms to screen for breast cancer. About half of them turn out to have dense breast tissue — which makes screening significantly more complicated. “It’s kind of a double whammy because dense breast tissue not only makes cancers harder to find, but people with denser tissue are more likely to get breast cancer,” said Laurie Margolies, a radiologist and vice chair for breast imaging at Mount Sinai.

355
355
article thumbnail

FDA looks to execute ‘largest reorganization in history’ this year

PharmaVoice

What started as an examination of the Human Foods Program has expanded into an agency-wide overhaul.

173
173
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to $2.2 billion as it seeks to bolster pipeline

STAT

LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion. The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue.

320
320
article thumbnail

Researchers advance blood tests’ ability to detect cancer earlier

Pharma Times

The advancement could allow earlier detection of cancer in the blood and better treatment

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: It’s time to remove skin color from the Apgar Score for newborns

STAT

In medicine, inertia can be a strangely powerful force, but Virginia Apgar never succumbed to it. She brought incredible energy to her work in anesthesia, neonatology, and dysmorphology (the study of birth defects) and questioned the status quo when she thought it might save lives. With gratitude for her tireless work, we have reevaluated the eponymous health assessment Apgar developed more than 70 years ago and concluded that one of its components — skin color — should be abandone

278
278
article thumbnail

FDA orders new cancer warnings for CAR-T therapies

BioPharma Dive

A black box warning for secondary T cell malignancies should be added to the labeling of all six approved CAR-T therapies, the agency said.

Labelling 125

More Trending

article thumbnail

Don’t forget clinical capacity of non-prescribers, urges GPhC

The Pharmacist

Recommendations made to the parliamentary pharmacy inquiry include giving greater powers to non-prescribing pharmacists to vary prescriptions and freeing up pharmacists for a more clinical, patient-facing role. Speaking to the health and social care committee (HSCC) last week, the chief executive of the General Pharmaceutical Council (GPhC) suggested that changes needed to be made to […] The post Don’t forget clinical capacity of non-prescribers, urges GPhC appeared first on The Pharmacist

124
124
article thumbnail

Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at some polarizing cancer data, a strange CEO transition, and the importance of New Year cheer.

article thumbnail

MIT researchers repurpose cancer compound to treat PKD

Pharma Times

Autosomal dominant polycystic kidney disease affects more than 12 million people globally

article thumbnail

STAT+: A for-profit health system’s financial issues could plunge overburdened hospitals into crisis

STAT

Steward Health Care, a for-profit health system that serves thousands of patients in Eastern Massachusetts, is in such grave financial distress that it may be unable to continue operating some facilities, according to public records and people with knowledge of the situation. The fast-moving crisis has left regulators racing to prevent the massive layoffs and erosion of care that could come if hospital services were to suddenly cease.

Hospitals 138
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Will new therapeutic agent replace antibodies for bacterial detection?

European Pharmaceutical Review

As a tool for detecting and identifying bacteria, aptamers are a promising new class of synthetic nucleic acid molecules that can be used to detect and treat of pathogenic bacteria. With the ability to be developed against a whole bacterium, a microbial toxin, or some proteins, for some bacteria, “aptamers against pathogens can not only supplement the deficiency of antibodies but can also enrich the aptamer database to develop efficient analytical regents”, according to a paper published in the

Immunity 116
article thumbnail

Lilly trumpets early success with deafness gene therapy

pharmaphorum

Eli Lilly’s gene therapy for otoferlin-related deafness has restored the hearing of the first child enrolled in its ongoing phase 1/2 trial

115
115
article thumbnail

Using Blockchain to Minimize Consumers’ Risk Aversion Toward Generic Drugs

Pharmaceutical Commerce

Study describes how a game theoretic model can successfully analyze how adoption of blockchain technology can reveal quality information.

110
110
article thumbnail

Sanofi snaps up Inhibrx and its rare disease drug for $2.2bn

pharmaphorum

Sanofi agrees $2.2bn deal to buy California biotech Inhibrx and its long-acting therapy for rare disease AATD, which causes life-threatening emphysema.

115
115
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pharmacist wellbeing ‘has patient safety implications'

The Pharmacist

Patient safety and wellbeing is ‘inextricably bound up’ with the wellbeing of the profession, the chief executive of the General Pharmaceutical Council (GPhC) has told MPs. Duncan Rudkin made the comments as part of an evidence session to the Health and Social Care Committee’s pharmacy inquiry, where together with other pharmacy representatives, he highlighted pressures […] The post Pharmacist wellbeing ‘has patient safety implications' appeared first on The Pharmacist.

106
106
article thumbnail

Take the hybrid road to bring clinical trials to patients

pharmaphorum

Bringing clinical trials to patients has become easier with the advent of digital technologies and decentralised clinical trials (DCTs). Learn how the hybrid approach combining traditional and digital methods can benefit patients and advance medical research.

111
111
article thumbnail

SII joins CEPI global network to boost production of affordable outbreak vaccines

Express Pharma

The Serum Institute of India (SII), is joining a CEPI network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future public health disease outbreaks. The addition of SII to the CEPI manufacturing network will be a significant boost to vaccine production efforts in Global South regions and will mean the world is better prepared to achieve the 100 Days Mission to develop new vaccines against known or novel infectious diseases within three months of

Vaccines 105
article thumbnail

Digital marketing firm Viseven gets private equity backing

pharmaphorum

Ukraine-based digital pharma marketing specialist Viseven gets private equity investment from Horizon Capital

110
110
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Sustainable nutrition fuses tradition with innovation for environmental and health benefits: GlobalData

Express Pharma

The field of sustainable nutrition is redefining the global food landscape by merging traditional dietary practices with innovative technologies. This evolution, driven by the urgent need for environmental sustainability and enhanced health benefits, is spotlighting alternative food sources and advanced production methods. This transformative trend is not just a fleeting movement but a crucial pivot towards a more sustainable future, finds GlobalData.

105
105
article thumbnail

NICE backs two AIs for stroke diagnosis in NHS

pharmaphorum

Two artificial intelligence-powered software tools – e-Stroke and RapidAI – have been recommended for use in the NHS to help detect stroke from CT brain scans by NICE. The health technology assessment (HTA) agency said there is some evidence that people admitted to hospital with a suspected had faster or better access to treatment after using the software, although for now it is unclear whether that was a direct consequence of the digital technology.

Hospitals 110
article thumbnail

UK MHRA strengthens regulations on fluoroquinolone antibiotics

Pharmaceutical Technology

The UK MHRA has introduced further restrictions on the usage of fluoroquinolone antibiotics, strengthening the previous regulations.

98
article thumbnail

Trial raises hopes for simple Alzheimer’s blood test

pharmaphorum

Study finds evidence that an AlZpath immunoassay for phosphorylated tau could deliver an effective blood test for Alzheimer's, paving the way for screening and early treatment

105
105
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Lupin gets tentative US FDA approval for Rivaroxaban Tablets USP

Express Pharma

Lupin has received tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg, and 20 mg, to market a generic equivalent of Xarelto Tablets, 2.5 mg, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals. This product will be manufactured at Lupin’s Pithampur facility in India.

98
article thumbnail

Fixing the inequity of drug access outside of the US

pharmaphorum

In this new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes guest Cem Zorluhar, CEO of Er-Kim Pharmaceuticals, for a conversation on antimicrobial resistance (AMR) and what the biotech industry should be focussing on in order to address this critical issue outside of the West.

98
article thumbnail

Genentech signs nanoparticle deal worth up to $644m with GenEdit

Pharmaceutical Technology

Genentech will utilise GenEdit’s non-viral polymer nanoparticles for gene therapy delivery in autoimmune diseases.

96
article thumbnail

Covid undervaccination led to thousands of deaths in UK

The Pharmacist

People not having all their recommended doses of the Covid vaccine led to thousands of unnecessary deaths and severe outcomes, researchers have found. Over 7,000 hospitalisations and deaths might have been avoided in summer 2022 if there had been ‘full’ Covid-19 vaccination coverage across the UK, according to a new study. Using health record data […] The post Covid undervaccination led to thousands of deaths in UK appeared first on The Pharmacist.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Bayer aims to sustainably improve performance with new organization

World Pharma News

The Bayer Group is introducing a new operating model called "Dynamic Shared Ownership" (DSO) worldwide, which will reduce hierarchies, eliminate bureaucracy, streamline structures and accelerate decision-making processes. The aim of the new operating model is to make the company much more agile and significantly improve its operational performance.

90
article thumbnail

Pharma manufacturer Gerresheimer gives Georgia an $88 million injection of funds

Outsourcing Pharma

Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its operations in Peachtree City, Georgia.

90
article thumbnail

Attending NHS Health Check linked to ‘significantly lower risk of disease’

The Pharmacist

Attending an NHS Health Check is associated with a lower risk of both death and several diseases, according to a new study. An observational study using UK Biobank participants, published today, found that among those who took up an NHS Health check there was a 19% lower rate of dementia diagnosis and 23% lower risk […] The post Attending NHS Health Check linked to ‘significantly lower risk of disease’ appeared first on The Pharmacist.

80
article thumbnail

Sano Genetics raises a further $11.4 million for its 'precision medicine revolution'

Outsourcing Pharma

Sano Genetics says it is developing software that will enable âthe precision medicine revolutionâ and has raised $11.4 million in new funding.

84
article thumbnail

Which pharmaceutical drugs have the most patents?

Drug Patent Watch

This chart shows the pharmaceutical drugs with the greatest number of patents still in force. The number of patents covering a drug can be indicative of the value of a… The post Which pharmaceutical drugs have the most patents? appeared first on DrugPatentWatch - Make Better Decisions.

72